Annual Total Liabilities
$61.40 M
-$12.39 M-16.80%
December 31, 2024
Summary
- As of March 15, 2025, DYN annual total liabilities is $61.40 million, with the most recent change of -$12.39 million (-16.80%) on December 31, 2024.
- During the last 3 years, DYN annual total liabilities has risen by +$3.93 million (+6.84%).
- DYN annual total liabilities is now -16.80% below its all-time high of $73.79 million, reached on December 31, 2023.
Performance
DYN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$61.40 M
-$1.91 M-3.01%
December 31, 2024
Summary
- As of March 15, 2025, DYN quarterly total liabilities is $61.40 million, with the most recent change of -$1.91 million (-3.01%) on December 31, 2024.
- Over the past year, DYN quarterly total liabilities has increased by +$10.71 million (+21.12%).
- DYN quarterly total liabilities is now -16.80% below its all-time high of $73.79 million, reached on December 31, 2023.
Performance
DYN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DYN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.8% | +21.1% |
| 3 y3 years | +6.8% | +37.8% |
| 5 y5 years | +2458.2% | +37.8% |
DYN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.8% | +13.8% | -16.8% | +38.8% |
| 5 y | 5-year | -16.8% | +2458.2% | -16.8% | +2458.2% |
| alltime | all time | -16.8% | +2458.2% | -16.8% | +2458.2% |
Dyne Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $61.40 M(-16.8%) | $61.40 M(-3.0%) |
| Sep 2024 | - | $63.30 M(+24.9%) |
| Jun 2024 | - | $50.69 M(+14.6%) |
| Mar 2024 | - | $44.22 M(-40.1%) |
| Dec 2023 | $73.79 M(+36.7%) | $73.79 M(+38.7%) |
| Sep 2023 | - | $53.21 M(+19.4%) |
| Jun 2023 | - | $44.54 M(-4.6%) |
| Mar 2023 | - | $46.71 M(-13.4%) |
| Dec 2022 | $53.96 M | $53.96 M(+8.1%) |
| Sep 2022 | - | $49.94 M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $52.97 M(+3.2%) |
| Mar 2022 | - | $51.30 M(-10.7%) |
| Dec 2021 | $57.47 M(+424.0%) | $57.47 M(+8.9%) |
| Sep 2021 | - | $52.76 M(+262.6%) |
| Jun 2021 | - | $14.55 M(+8.2%) |
| Mar 2021 | - | $13.45 M(+22.6%) |
| Dec 2020 | $10.97 M(+357.0%) | $10.97 M(-25.0%) |
| Sep 2020 | - | $14.63 M(+2.4%) |
| Jun 2020 | - | $14.29 M(+495.4%) |
| Dec 2019 | $2.40 M(-81.7%) | $2.40 M |
| Dec 2018 | $13.15 M | - |
FAQ
- What is Dyne Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Dyne Therapeutics?
- What is Dyne Therapeutics annual total liabilities year-on-year change?
- What is Dyne Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly total liabilities year-on-year change?
What is Dyne Therapeutics annual total liabilities?
The current annual total liabilities of DYN is $61.40 M
What is the all time high annual total liabilities for Dyne Therapeutics?
Dyne Therapeutics all-time high annual total liabilities is $73.79 M
What is Dyne Therapeutics annual total liabilities year-on-year change?
Over the past year, DYN annual total liabilities has changed by -$12.39 M (-16.80%)
What is Dyne Therapeutics quarterly total liabilities?
The current quarterly total liabilities of DYN is $61.40 M
What is the all time high quarterly total liabilities for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly total liabilities is $73.79 M
What is Dyne Therapeutics quarterly total liabilities year-on-year change?
Over the past year, DYN quarterly total liabilities has changed by +$10.71 M (+21.12%)